Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells

Naeme Javid1, Shahriyar Abdoli2, Majid Shahbazi3,4

  • 1Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Frontiers in Oncology
|January 24, 2025
PubMed
Abstract

Insights

Oncolytic herpes simplex viruses (oHSVs) target cancer cells. This study analyzed gene expression changes in oHSV-1 infected cells, identifying proteasome pathway alterations and key genes like GADD45g for potential therapeutic strategies.

Area of Science:

  • Oncology
  • Virology
  • Genomics
  • Systems Biology

Background:

  • Oncolytic herpes simplex viruses (oHSVs) are promising biotherapeutics for cancer treatment, selectively targeting and destroying tumor cells.
  • Understanding the host cell's genomic and metabolic response to oHSV infection is crucial for optimizing their therapeutic efficacy.

Purpose of the Study:

  • To investigate the functional genomic and metabolic pathway alterations in human cancer cells upon infection with oHSV-1.
  • To identify key genes and pathways influenced by oHSV-1 infection that modulate the virus-cancer cell interaction.
  • To explore the potential of transcriptome changes for predicting oncolytic virus efficacy.

Main Methods:

  • Utilized two gene expression datasets from the Gene Expression Omnibus (GEO) database for tumor cells infected with oHSV-1 (G207) and control cells.
  • Processed and normalized data using R software, identifying common differentially expressed genes and hub genes.
  • Validated hub gene expression using real-time quantitative polymerase chain reaction (qRT-PCR) in MDA-MB-231 breast cancer cells.

Main Results:

  • Significant alterations in proteasome pathway-related genes were observed between infected and non-infected cells, with the proteasome-mediated ubiquitin-dependent protein catabolic process identified as a key biological pathway (p-value: 5.8E-21).
  • Extracellular exosomes and protein binding were identified as significant cellular components and molecular functions, respectively.
  • Key hub genes including PSMD2, PSMD4, PSMA2, and GADD45g were identified, with GADD45g showing potential in oncolytic HSV-1 proliferation.

Conclusions:

  • Transcriptome analysis reveals significant host cell responses to oHSV-1 infection, particularly involving the proteasome pathway.
  • Identified hub genes and pathways provide insights into the virus-cancer cell dynamics.
  • These findings can inform the development of next-generation oncolytic viruses and predict their therapeutic efficacy.

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...